Molecular Cancer Therapeutics
Impact Factor & Key Scientometrics

Molecular Cancer Therapeutics
Overview

Impact Factor

6.261

H Index

199

Impact Factor

5.529

I. Basic Journal Info

Country

United States
Journal ISSN: 15357163, 15388514
Publisher: American Association for Cancer Research
History: 2001-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

II. Science Citation Report (SCR)



Molecular Cancer Therapeutics
SCR Impact Factor

Molecular Cancer Therapeutics
SCR Journal Ranking

Molecular Cancer Therapeutics
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

2.717

Molecular Cancer Therapeutics
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Molecular Cancer Therapeutics
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Molecular Cancer Therapeutics
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Molecular Cancer Therapeutics
Impact Factor History

2-year 3-year 4-year
  • 2023 Impact Factor
    #N/A #N/A #N/A
  • 2022 Impact Factor
    5.381 5.655 5.971
  • 2021 Impact Factor
    5.529 6.33 6.791
  • 2020 Impact Factor
    5.347 6.265 6.258
  • 2019 Impact Factor
    5.443 5.453 5.549
  • 2018 Impact Factor
    5.101 5.493 5.727
  • 2017 Impact Factor
    5.425 5.896 5.83
  • 2016 Impact Factor
    6.069 6.072 6.226
  • 2015 Impact Factor
    5.936 6.482 6.735
  • 2014 Impact Factor
    5.971 NA NA
  • 2013 Impact Factor
    6.608 NA NA
  • 2012 Impact Factor
    5.982 NA NA
  • 2011 Impact Factor
    5.615 NA NA
  • 2010 Impact Factor
    5.683 NA NA
  • 2009 Impact Factor
    5.534 NA NA
  • 2008 Impact Factor
    5.311 NA NA
  • 2007 Impact Factor
    5.11 NA NA
  • 2006 Impact Factor
    5.579 NA NA
  • 2005 Impact Factor
    5.504 NA NA
  • 2004 Impact Factor
    5.965 NA NA
  • 2003 Impact Factor
    3.539 NA NA
  • 2002 Impact Factor
    2.412 NA NA
  • 2001 Impact Factor
    0 NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Molecular Cancer Therapeutics
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

199

Molecular Cancer Therapeutics
H-Index History